Bristol-Myers’

US FDA approves Bristol Myers’ oral heart disease drug

Read more

Nektar stops clinical trials for key cancer drug

Read more

US FDA approves new Bristol Myers cancer immunotherapy

Read more

US FDA approves CTI BioPharma’s bone marrow cancer drug

Read more

WuXi STA completes acquisition of Bristol Myers Squibb manufacturing facility in Switzerland

Read more

USFDA extends review of Bristol Myers’ cancer therapy acquired in Celgene deal

Read more

Bluebird bio, Bristol-Myers’ multiple myeloma therapy shows promise in early study

Read more